Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Jul;17(1):187–194. doi: 10.1128/iai.17.1.187-194.1977

Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis.

R D Diamond
PMCID: PMC421100  PMID: 885613

Abstract

A model of cryptococcosis was developed using intraperitoneal infections of guinea pigs. This model shared characteristics with cryptococcosis in humans and was used to study the effects of immunosuppression and immunostimulation on cryptococcosis. Female guniea pigs survived longer than males; perphaps this was related to a greater capacity of their monocytes to kill cryptococci. A brief course of cortisone shortened survival of females and resulted in depressed immune and inflammatory responses, which persisted long after cortisone was stopped. Stimulation of the immune response by treatment with cryptococci in Freund complete adjuvant improved survival in males. Preliminary studies indicated the usefulness of this model for the study of other potential immunostimulants, including immune lymphocytes, transfer factor prepared from immune lymphocytes, and levamisole. Overall, long-term survivors appeared to clear disseminated cryptococci from extraperitoneal sites including brain, rather than prevent dissemination of cryptococci from the peritoneal cavity. The quantity of the inflammatory response in infectious foci, rather than the ability of individual leukocytes to kill crytococci, may have determined the outcome of most infections.

Full text

PDF
187

Images in this article

190Image
on p.190
191Image
on p.191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. E., Bailey J. W. Control for rheumatoid factor in the latex test for cryptococcosis. Am J Clin Pathol. 1971 Sep;56(3):360–365. doi: 10.1093/ajcp/56.3.360. [DOI] [PubMed] [Google Scholar]
  2. Bindschadler D. D., Bennett J. E. Serology of human cryptococcosis. Ann Intern Med. 1968 Jul;69(1):45–52. doi: 10.7326/0003-4819-69-1-45. [DOI] [PubMed] [Google Scholar]
  3. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  4. Casey W. J., McCall C. E. Suppression of the cellular interactions of delayed hypersensitivity by corticosteroid. Immunology. 1971 Aug;21(2):225–231. [PMC free article] [PubMed] [Google Scholar]
  5. Claman H. N. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. doi: 10.1056/NEJM197208242870806. [DOI] [PubMed] [Google Scholar]
  6. Diamond R. D., Allison A. C. Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect Immun. 1976 Sep;14(3):716–720. doi: 10.1128/iai.14.3.716-720.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Diamond R. D., Bennett J. E. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. J Infect Dis. 1973 Jun;127(6):694–697. doi: 10.1093/infdis/127.6.694. [DOI] [PubMed] [Google Scholar]
  8. Diamond R. D., Bennett J. E. Growth of Cryptococcus neoformans within human macrophages in vitro. Infect Immun. 1973 Feb;7(2):231–236. doi: 10.1128/iai.7.2.231-236.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Diamond R. D., Bennett J. E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974 Feb;80(2):176–181. doi: 10.7326/0003-4819-80-2-176. [DOI] [PubMed] [Google Scholar]
  10. Diamond R. D., Root R. K., Bennett J. E. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis. 1972 Apr;125(4):367–376. doi: 10.1093/infdis/125.4.367. [DOI] [PubMed] [Google Scholar]
  11. Fauci A. S. Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. Immunology. 1975 Apr;28(4):669–680. [PMC free article] [PubMed] [Google Scholar]
  12. Graybill J. R., Alford R. H. Cell-mediated immunity in Cryptococcosis. Cell Immunol. 1974 Oct;14(1):12–21. doi: 10.1016/0008-8749(74)90164-6. [DOI] [PubMed] [Google Scholar]
  13. Grosse G., Mishra S. K., Staib F. Selective involvement of the brain in experimental murine cryptococcosis. II. Histopathological observations. Zentralbl Bakteriol Orig A. 1975 Sep;233(1):106–122. [PubMed] [Google Scholar]
  14. Kalina M., Kletter Y., Aronson M. The interaction of phagocytes and the large-sized parasite Cryptococcus neoformans: cytochemical and ultrastructural study. Cell Tissue Res. 1974;152(2):165–174. doi: 10.1007/BF00224692. [DOI] [PubMed] [Google Scholar]
  15. Kenny J. F., Pangburn P. C., Trail G. Effect of estradiol on immune competence: in vivo and in vitro studies. Infect Immun. 1976 Feb;13(2):448–456. doi: 10.1128/iai.13.2.448-456.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mitchell T. G., Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect Immun. 1972 Apr;5(4):491–498. doi: 10.1128/iai.5.4.491-498.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mohr J. A., Long H., McKown B. A., Muchmore H. G. In vitro susceptibility of Cryptococcus neoformans to steroids. Sabouraudia. 1972 Jul;10(2):171–172. [PubMed] [Google Scholar]
  18. Mohr J. A., Muchmore H. G., Tacker R. Stimulation of phagocytosis of Cryptococcus neoformans in human cryptococcal meningitis. J Reticuloendothel Soc. 1974 Feb;15(2):149–154. [PubMed] [Google Scholar]
  19. Nicol T., Vernon-Roberts B., Quantock D. C. The influence of various hormones on the reticulo-endothelial system: endocrine control of body defense. J Endocrinol. 1965 Nov;33(3):365–383. doi: 10.1677/joe.0.0330365. [DOI] [PubMed] [Google Scholar]
  20. North R. J. The action of cortisone acetate on cell-mediated immunity to infection. Suppression of host cell proliferation and alteration of cellular composition of infective foci. J Exp Med. 1971 Dec 1;134(6):1485–1500. doi: 10.1084/jem.134.6.1485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. OREN R., FARNHAM A. E., SAITO K., MILOFSKY E., KARNOVSKY M. L. Metabolic patterns in three types of phagocytizing cells. J Cell Biol. 1963 Jun;17:487–501. doi: 10.1083/jcb.17.3.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Powell K. E., Dahl B. A., Weeks R. J., Tosh F. E. Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition. J Infect Dis. 1972 Apr;125(4):412–415. doi: 10.1093/infdis/125.4.412. [DOI] [PubMed] [Google Scholar]
  23. Schimpff S. C., Bennett J. E. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J Allergy Clin Immunol. 1975 Jun;55(6):430–441. doi: 10.1016/0091-6749(75)90082-2. [DOI] [PubMed] [Google Scholar]
  24. Song M. M. Experimental cryptococcosis of the skin. Sabouraudia. 1974 Jul;12(2):133–137. doi: 10.1080/00362177485380191. [DOI] [PubMed] [Google Scholar]
  25. Staib F., Mishra S. K. Selective involvement of the brain in experimental murine cryptococcosis. I. Microbiological observations. Zentralbl Bakteriol Orig A. 1975 Jul;232(2-3):355–364. [PubMed] [Google Scholar]
  26. Tacker J. R., Farhi F., Bulmer G. S. Intracellular fate of Cryptococcus neoformans. Infect Immun. 1972 Aug;6(2):162–167. doi: 10.1128/iai.6.2.162-167.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES